Chemical NameGa-68-DOTATOC
Dosage FormInjectable (intravenous; 18.5 MBq/mL to 148 MBq/mL (0.5 mCi/mL to 4 mCi/mL))
Drug ClassRadioactive diagnostic agents
SystemNervous, Endocrine
CompanyUIHC PET Imaging
Approval Year2019


  • Ga-68-DOTATOC is indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients.
Last updated on 11/10/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Ga-68-DOTATOC Prescribing Information 2019UIHC PET Imaging